What are the criteria for low-, moderate-, and high-risk surgical clearance and the recommended pre-operative evaluation for each risk category?

Surgical Risk Stratification and Pre-operative Evaluation

Surgical risk is stratified into low (<1% risk of major adverse cardiac events [MACE]), intermediate (1-5% risk), and high (>5% risk) categories based on combined clinical and surgical factors, with pre-operative evaluation intensity escalating accordingly. 1

Risk Categories and Definitions

Low-Risk Surgery (MACE <1%)

• Examples: Ophthalmologic procedures, superficial biopsies, breast surgery, minor dental/dermatological procedures 1
• Pre-operative evaluation:
  • No further cardiac testing needed—proceed directly to surgery 1
  • Routine ECG not indicated for asymptomatic patients 1
  • Continue guideline-directed medical therapy (GDMT) 1

Intermediate-Risk Surgery (MACE 1-5%)

• Examples: Intraperitoneal/intrathoracic procedures, carotid endarterectomy, head/neck surgery, orthopedic surgery, prostate surgery 1, 2
• Pre-operative evaluation:
  • Assess functional capacity using Duke Activity Status Index (DASI) or metabolic equivalents (METs) 1
  • If ≥4 METs: proceed to surgery without further testing 1, 2
  • If <4 METs or unknown capacity: consider stress testing only if results will change management 1
  • Baseline ECG reasonable for patients with ≥1 cardiac risk factor 2

High-Risk Surgery (MACE >5%)

• Examples: Major vascular surgery (aortic, peripheral vascular), open abdominal aortic aneurysm repair 1
• Pre-operative evaluation:
  • Calculate combined clinical/surgical risk using NSQIP calculator or Revised Cardiac Risk Index (RCRI) 1
  • Assess functional capacity with DASI 1
  • If ≥4 METs: proceed to surgery 1
  • If <4 METs: pharmacological stress testing (dobutamine stress echo or myocardial perfusion imaging) if results will impact decision-making 1
  • Consider coronary angiography only if extensive ischemia detected and revascularization would be pursued 1

Clinical Risk Stratification Algorithm

Step 1: Determine surgery urgency 1

• Emergency: proceed with appropriate monitoring, no delay for testing 3
• Urgent/semi-urgent: assess only for unstable cardiac conditions, severe valvular disease, or severe pulmonary hypertension 3
• Elective: proceed with full evaluation 3

Step 2: Screen for acute coronary syndrome (ACS) 1

• If present: cardiology consultation and management per ACS guidelines before surgery 1

Step 3: Calculate MACE risk using RCRI plus surgical risk 1

RCRI Components (1 point each): 3

• History of ischemic heart disease
• History of heart failure
• History of cerebrovascular disease
• Insulin-dependent diabetes
• Creatinine >177 μmol/L (>2.0 mg/dL)
• High-risk surgery

Step 4: If MACE risk <1%, proceed to surgery 1

Step 5: If elevated MACE risk, assess functional capacity 1

• ≥4 METs (can climb 2 flights of stairs, perform heavy housework, participate in strenuous sports): proceed to surgery 1
• <4 METs: proceed to Step 6 1

Step 6: For poor/unknown functional capacity, determine if testing will change management 1

• If yes: pharmacological stress testing appropriate 1
• If no: proceed to surgery with GDMT or consider alternatives 1

Pre-operative Testing Recommendations

ECG

• Reasonable (Class IIa): Known CAD, significant arrhythmia, peripheral arterial disease, cerebrovascular disease, or structural heart disease undergoing intermediate/high-risk surgery 1
• Not indicated: Asymptomatic patients undergoing low-risk surgery 1

Left Ventricular Function Assessment

• Reasonable: Dyspnea of unknown origin or worsening heart failure symptoms 1
• Not routine: Clinically stable patients 1

Stress Testing

• Reasonable: Elevated risk patients with poor functional capacity if results will change management 1
• Not indicated: Low-risk surgery regardless of clinical factors 1

Patient Population Requiring Evaluation

Formal cardiac risk assessment applies to: 3

• Patients ≥45 years undergoing surgery requiring overnight hospitalization 3
• Patients 18-44 years with known significant cardiovascular disease (CAD, cerebrovascular disease, peripheral arterial disease, heart failure, severe pulmonary hypertension, severe valvular disease) 3

Critical Pitfalls

Avoid over-testing: The 2014 ACC/AHA guidelines emphasize that routine screening with noninvasive stress testing provides no benefit for low-risk surgery 1. The key decision point is whether testing will actually change management—if not, proceed directly to surgery with medical optimization 1.

Functional capacity is paramount: Patients with good functional capacity (≥4 METs) can proceed to intermediate or high-risk surgery without further cardiac testing, even with multiple risk factors 1, 2. This represents a major shift from older approaches that emphasized extensive pre-operative testing.

Emergency surgery: Never delay emergency surgery for cardiac evaluation—proceed with appropriate monitoring and management based on clinical assessment 3.